Tag: Molnupiravir

spot_img
COVID-19

Molnupiravir becomes the first Oral Antiviral Drug to be included in WHO’s living Guidelines on COVID-19 Therapeutics 

SCIEU Team -
WHO has updated its living guidelines on COVID-19 therapeutics. The ninth update released on 03 March 2022 include a conditional recommendation on molnupiravir.  Molnupiravir has...
COVID-19

Could Merck’s Molnupiravir and Pfizer’s Paxlovid, the Two New Anti-Viral Drugs Against COVID-19 Hasten the End of the Pandemic?

Umesh Prasad and Rajeev Soni -
Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes...
COVID-19

Molnupiravir: A Game Changing Oral Pill for Treatment of COVID-19

Rajeev Soni -
Molnupiravir, a nucleoside analog of cytidine, a drug that has shown excellent oral bioavailability and promising results in Phase 1 and Phase 2 trials, could prove...

Stay in touch:

87,845FansLike
45,152FollowersFollow
1,772FollowersFollow
49SubscribersSubscribe

Newsletter

Don't miss

ENGINEERING & TECHNOLOGY

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

0
The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...
MEDICINE

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

0
Cancer cells have electrically charged parts hence are influenced...
SPONSORED CONTENT

Scientific European invites Co-founder

0
Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...
PHYSICS

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

0
The quest for the answers to the open questions (such as, which...
BIOLOGY

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

0
In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...